Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis

Unfavorable clinical outcomes mean that cancer researchers must attempt to develop novel therapeutic strategies to overcome therapeutic resistance in patients with HNSCC. Recently, ferroptosis was shown to be a promising pathway possessing druggable targets, such as xCT (SLC7A11). Unfortunately, lit...

Descripción completa

Detalles Bibliográficos
Autores principales: Savic, Dragana, Steinbichler, Teresa Bernadette, Ingruber, Julia, Negro, Giulia, Aschenbrenner, Bertram, Riechelmann, Herbert, Ganswindt, Ute, Skvortsov, Sergej, Dudás, József, Skvortsova, Ira-Ida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856753/
https://www.ncbi.nlm.nih.gov/pubmed/36672272
http://dx.doi.org/10.3390/cells12020336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856753/
https://www.ncbi.nlm.nih.gov/pubmed/36672272
http://dx.doi.org/10.3390/cells12020336

Ejemplares similares